Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides

Bioorganic & Medicinal Chemistry
2008.0

Abstract

Inhibitors of histone deacetylases (HDACs) are a promising class of anticancer agents that effect gene regulation. To know the interaction of aliphatic cap groups with HDACs, cyclic tetrapeptide and bicyclic peptide disulfide hybrids were synthesized without aromatic ring in their macrocyclic framework. Benzene ring of l-Phe in chlamydocin was replaced with several aliphatic amino acids and also a fused bicyclic tetrapeptide was synthesized by ring closing metathesis using Grubb's first generation catalyst. The inhibitory activities of the cyclic peptides against histone deacetylase enzymes were evaluated, which demonstrated most of them are interesting candidates as anticancer agents.

Knowledge Graph

Similar Paper

Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides
Bioorganic & Medicinal Chemistry 2008.0
Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework
Bioorganic & Medicinal Chemistry 2007.0
Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand
Bioorganic & Medicinal Chemistry Letters 2004.0
Bicyclic peptides as potent inhibitors of histone deacetylases: Optimization of alkyl loop length
Bioorganic & Medicinal Chemistry Letters 2010.0
Design and Synthesis of a Potent Histone Deacetylase Inhibitor
Journal of Medicinal Chemistry 2007.0
Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases
Bioorganic & Medicinal Chemistry Letters 2012.0
Discovery of Potent and Selective Histone Deacetylase Inhibitors via Focused Combinatorial Libraries of Cyclic α<sub>3</sub>β-Tetrapeptides
Journal of Medicinal Chemistry 2009.0
Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones
Bioorganic &amp; Medicinal Chemistry Letters 2004.0
RETRACTED: Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors
Bioorganic &amp; Medicinal Chemistry 2014.0
Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents
Bioorganic &amp; Medicinal Chemistry Letters 2008.0